Ann: MX1 - $8M contract signed with Australian Stroke Alliance, page-10

I was looking at this - an inexperienced limited assessment.
EMV - one marketable device - mobile medical imaging for ambulances, flying doc. No FDA approval to date. Market cap $218.6 million SP $2.99.

MX1 Four marketable devices, FDA approval for medical imaging. Market Cap $142.6 SP .31c.

There will be other factors I have not considered but the EMV comparison increases my confidence that MX1 is undervalued and is due a rerate.

Regards